350 related articles for article (PubMed ID: 24043904)
21. Anti-CD73 therapy impairs tumor angiogenesis.
Allard B; Turcotte M; Spring K; Pommey S; Royal I; Stagg J
Int J Cancer; 2014 Mar; 134(6):1466-73. PubMed ID: 23982901
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
Blumenthal RD; Hansen HJ; Goldenberg DM
Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells.
Airas L; Niemelä J; Salmi M; Puurunen T; Smith DJ; Jalkanen S
J Cell Biol; 1997 Jan; 136(2):421-31. PubMed ID: 9015312
[TBL] [Abstract][Full Text] [Related]
25. CD73-deficient mice are resistant to carcinogenesis.
Stagg J; Beavis PA; Divisekera U; Liu MC; Möller A; Darcy PK; Smyth MJ
Cancer Res; 2012 May; 72(9):2190-6. PubMed ID: 22396496
[TBL] [Abstract][Full Text] [Related]
26. A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms.
Stefano JE; Lord DM; Zhou Y; Jaworski J; Hopke J; Travaline T; Zhang N; Wong K; Lennon A; He T; Bric-Furlong E; Cherrie C; Magnay T; Remy E; Brondyk W; Qiu H; Radošević K
J Biol Chem; 2020 Dec; 295(52):18379-18389. PubMed ID: 33122192
[TBL] [Abstract][Full Text] [Related]
27. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
28. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model.
Kyutoku M; Taniyama Y; Katsuragi N; Shimizu H; Kunugiza Y; Iekushi K; Koibuchi N; Sanada F; Oshita Y; Morishita R
Int J Mol Med; 2011 Aug; 28(2):181-6. PubMed ID: 21617848
[TBL] [Abstract][Full Text] [Related]
29. CD73 expression and fyn-dependent signaling on murine lymphocytes.
Yamashita Y; Hooker SW; Jiang H; Laurent AB; Resta R; Khare K; Coe A; Kincade PW; Thompson LF
Eur J Immunol; 1998 Oct; 28(10):2981-90. PubMed ID: 9808167
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model.
Sociali G; Raffaghello L; Magnone M; Zamporlini F; Emionite L; Sturla L; Bianchi G; Vigliarolo T; Nahimana A; Nencioni A; Raffaelli N; Bruzzone S
Oncotarget; 2016 Jan; 7(3):2968-84. PubMed ID: 26658104
[TBL] [Abstract][Full Text] [Related]
31. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
[TBL] [Abstract][Full Text] [Related]
32. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
Wang L; Zhou X; Zhou T; Ma D; Chen S; Zhi X; Yin L; Shao Z; Ou Z; Zhou P
J Cancer Res Clin Oncol; 2008 Mar; 134(3):365-72. PubMed ID: 17671792
[TBL] [Abstract][Full Text] [Related]
33. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
[TBL] [Abstract][Full Text] [Related]
34. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis.
Testa JE; Brooks PC; Lin JM; Quigley JP
Cancer Res; 1999 Aug; 59(15):3812-20. PubMed ID: 10447000
[TBL] [Abstract][Full Text] [Related]
35. Giardia duodenalis: biochemical characterization of an ecto-5'-nucleotidase activity.
Russo-Abrahão T; Cosentino-Gomes D; Daflon-Yunes N; Meyer-Fernandes JR
Exp Parasitol; 2011 Jan; 127(1):66-71. PubMed ID: 20599434
[TBL] [Abstract][Full Text] [Related]
36. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
37. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
38. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy induces enrichment of CD47
Samanta D; Park Y; Ni X; Li H; Zahnow CA; Gabrielson E; Pan F; Semenza GL
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1239-E1248. PubMed ID: 29367423
[TBL] [Abstract][Full Text] [Related]
40. CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy.
Chen S; Fan J; Zhang M; Qin L; Dominguez D; Long A; Wang G; Ma R; Li H; Zhang Y; Fang D; Sosman J; Zhang B
Nat Commun; 2019 Jan; 10(1):150. PubMed ID: 30635578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]